Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Flower

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Human Genetics|May 15, 2024
Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington diseaseRoss Ferguson, Robert Goold, Lucy Coupland, et al.
Emerging Topics in Life Sciences|October 20, 2023
Genetic modifiers of repeat expansion disordersSangeerthana Rajagopal, Jasmine Donaldson, Michael Flower, et al.
NAR Molecular Medicine|June 19, 2026
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansionRob Goold, Jasmine Donaldson, Florence Gidney, et al.
Glia|November 13, 2021
Dystrophin deficiency affects human astrocyte properties and response to damageJenny Lange, Olivia Gillham, Reem Alkharji, et al.
Progress in Neurobiology|April 6, 2023
PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington's diseaseJenny Lange, Olivia Gillham, Michael Flower, et al.
Brain : a Journal of Neurology|June 20, 2019
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1Michael Flower, Vilija Lomeikaite, Marc Ciosi, et al.
Brain Communications|December 15, 2022
Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington's diseaseMarina Papoutsi, Michael Flower, Davina J Hensman Moss, et al.
Human Molecular Genetics|October 26, 2018
FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeatRobert Goold, Michael Flower, Davina Hensman Moss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2024
Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing explorationCarolin Anna Maria Koriath, Fernando Guntoro, Penelope Norsworthy, et al.
Genome Biology|September 7, 2022
Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissuesAndreas Neueder, Kerstin Kojer, Tanja Hering, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Human Genetics|May 15, 2024
Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington diseaseRoss Ferguson, Robert Goold, Lucy Coupland, et al.
Emerging Topics in Life Sciences|October 20, 2023
Genetic modifiers of repeat expansion disordersSangeerthana Rajagopal, Jasmine Donaldson, Michael Flower, et al.
NAR Molecular Medicine|June 19, 2026
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansionRob Goold, Jasmine Donaldson, Florence Gidney, et al.
Glia|November 13, 2021
Dystrophin deficiency affects human astrocyte properties and response to damageJenny Lange, Olivia Gillham, Reem Alkharji, et al.
Progress in Neurobiology|April 6, 2023
PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington's diseaseJenny Lange, Olivia Gillham, Michael Flower, et al.
Brain : a Journal of Neurology|June 20, 2019
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1Michael Flower, Vilija Lomeikaite, Marc Ciosi, et al.
Brain Communications|December 15, 2022
Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington's diseaseMarina Papoutsi, Michael Flower, Davina J Hensman Moss, et al.
Human Molecular Genetics|October 26, 2018
FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeatRobert Goold, Michael Flower, Davina Hensman Moss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2024
Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing explorationCarolin Anna Maria Koriath, Fernando Guntoro, Penelope Norsworthy, et al.
Genome Biology|September 7, 2022
Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissuesAndreas Neueder, Kerstin Kojer, Tanja Hering, et al.
Pageof 2